PCNA and neoplasm: Nevertheless, NKp30 has been shown to recognize a tumor cell ligand of the B7 family, B7-H6 (Brandt et al., 2009) and NKp44 is suggested to recognize proliferating cell nuclear antigen (PCNA), which surprisingly triggers inhibition of NK cells (Rosental et al., 2011).